Bing Shu

1.0k total citations
49 papers, 787 citations indexed

About

Bing Shu is a scholar working on Organic Chemistry, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Bing Shu has authored 49 papers receiving a total of 787 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Organic Chemistry, 17 papers in Molecular Biology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Bing Shu's work include Catalytic C–H Functionalization Methods (20 papers), Synthesis and Catalytic Reactions (13 papers) and Cyclopropane Reaction Mechanisms (11 papers). Bing Shu is often cited by papers focused on Catalytic C–H Functionalization Methods (20 papers), Synthesis and Catalytic Reactions (13 papers) and Cyclopropane Reaction Mechanisms (11 papers). Bing Shu collaborates with scholars based in China, Canada and Australia. Bing Shu's co-authors include Shang‐Shi Zhang, Hui Xie, Ding Li, Zhi‐Shu Huang, Luyong Zhang, Yanzhi Liu, Mei Zhong, Shaoyong Chen, Meiling Zhang and Xiaotong Wang and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and Chemical Communications.

In The Last Decade

Bing Shu

48 papers receiving 776 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bing Shu China 19 457 231 74 43 41 49 787
Heng Xu China 18 371 0.8× 328 1.4× 15 0.2× 58 1.3× 45 1.1× 56 728
Marika Salvalaio Italy 13 122 0.3× 188 0.8× 15 0.2× 48 1.1× 26 0.6× 16 578
Jung Lee United States 13 187 0.4× 260 1.1× 43 0.6× 44 1.0× 6 0.1× 26 458
Jing Xia China 11 68 0.1× 276 1.2× 70 0.9× 44 1.0× 21 0.5× 30 552
Arun Kumar Mahato India 13 78 0.2× 94 0.4× 93 1.3× 21 0.5× 7 0.2× 33 422
Yan‐Hong Jiang China 14 271 0.6× 440 1.9× 10 0.1× 30 0.7× 16 0.4× 36 793
Junwei Zhao China 12 72 0.2× 160 0.7× 23 0.3× 68 1.6× 15 0.4× 30 403
Xuemei Deng China 13 157 0.3× 296 1.3× 37 0.5× 20 0.5× 15 0.4× 37 551
Carla Vetrugno Italy 16 84 0.2× 251 1.1× 43 0.6× 27 0.6× 32 0.8× 29 605

Countries citing papers authored by Bing Shu

Since Specialization
Citations

This map shows the geographic impact of Bing Shu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing Shu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing Shu more than expected).

Fields of papers citing papers by Bing Shu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bing Shu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing Shu. The network helps show where Bing Shu may publish in the future.

Co-authorship network of co-authors of Bing Shu

This figure shows the co-authorship network connecting the top 25 collaborators of Bing Shu. A scholar is included among the top collaborators of Bing Shu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bing Shu. Bing Shu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Fan, Tian-You, et al.. (2024). Network pharmacology and experimental validation to reveal the pharmacological mechanisms of Astragaloside Ⅳ in treating intervertebral disc degeneration. European Journal of Pharmacology. 982. 176951–176951. 4 indexed citations
4.
Ren, Sen, Hewei Xiong, Qian Wu, et al.. (2024). The Rejuvenation and Functional Restoration of Aged Adipose Stem Cells by DUXAP10 Knockdown via the Regulation of the miR-214-3p/RASSF5 Axis. Stem Cells Translational Medicine. 13(5). 462–476. 4 indexed citations
5.
Yang, Zhaoyong, et al.. (2024). Rhodium-catalyzed C–H α-fluoroalkenylation/annulation of β-ketosulfoxonium ylides with 2,2-difluorovinyl tosylate/oxadiazolones. Chemical Communications. 60(100). 15000–15003. 2 indexed citations
6.
Wei, Zu‐Zhuang, Xiaomin Lin, Siyi Wang, et al.. (2023). Syntheses and evaluation of acridone derivatives as anticancer agents targeting Kras promoter i-motif structure. Bioorganic Chemistry. 136. 106526–106526. 8 indexed citations
7.
Gong, Xue, et al.. (2023). Regulation of c-Kit gene transcription selectively by bisacridine derivative through promoter dual i-motif structures. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1866(2). 194912–194912. 7 indexed citations
9.
Liu, Yanzhi, Yao‐Fu Zeng, Bing Shu, et al.. (2022). Rh(iii)-Catalyzed dienylation and cyclopropylation of indoles at the C4 position with alkylidenecyclopropanes. Organic Chemistry Frontiers. 9(16). 4287–4293. 8 indexed citations
11.
Xie, Hui, Yao‐Fu Zeng, Bing Shu, et al.. (2021). Mild Synthesis of 3,4-Dihydroisoquinolin-1(2H)-ones via Rh(III)-Catalyzed Tandem C–H-Allylation/N-Alkylation Annulation with 2-Methylidenetrimethylene Carbonate. The Journal of Organic Chemistry. 86(23). 17063–17070. 7 indexed citations
12.
Zhang, Shang‐Shi, Shaoyong Chen, Hui Xie, et al.. (2021). Access to Branched Allylarenes via Rhodium(III)-Catalyzed C–H Allylation of (Hetero)arenes with 2-Methylidenetrimethylene Carbonate. Organic Letters. 23(15). 5719–5723. 27 indexed citations
13.
Cao, Jiaojiao, Meiling Zhang, Xiaoya Li, et al.. (2021). Transcriptional regulation of telomeric repeat-containing RNA by acridine derivatives. RNA Biology. 18(12). 2261–2277. 5 indexed citations
14.
Shu, Bing, et al.. (2019). Synthesis and biological evaluation of novel indole-pyrazoline hybrid derivatives as potential topoisomerase 1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 30(4). 126925–126925. 19 indexed citations
15.
Shu, Bing, Xiaodan Sun, Raynald Liu, et al.. (2018). Restoring electrical connection using a conductive biomaterial provides a new therapeutic strategy for rats with spinal cord injury. Neuroscience Letters. 692. 33–40. 38 indexed citations
16.
Shu, Bing, Ping Zeng, Penghui Li, et al.. (2018). Syntheses and evaluation of new Quinoline derivatives for inhibition of hnRNP K in regulating oncogene c-myc transcription. Bioorganic Chemistry. 85. 1–17. 21 indexed citations
17.
Cao, Jiaojiao, Mingxue Wang, Bing Shu, et al.. (2017). Interaction of Quindoline derivative with telomeric repeat–containing RNA induces telomeric DNA-damage response in cancer cells through inhibition of telomeric repeat factor 2. Biochimica et Biophysica Acta (BBA) - General Subjects. 1861(12). 3246–3256. 26 indexed citations
18.
Yu, Hao, Lusheng Li, Raynald Liu, et al.. (2016). Autophagy in long propriospinal neurons is activated after spinal cord injury in adult rats. Neuroscience Letters. 634. 138–145. 7 indexed citations
19.
Shu, Bing, Yan Zheng, Shi‐Ben Wang, Xian‐Qing Deng, & Zhe‐Shan Quan. (2012). Design, Synthesis, and Anticonvulsant Activity Evaluation of 4‐(3‐Alkoxy‐phenyl)‐2,4‐dihydro‐[1,2,4]triazol‐3‐ones. Archiv der Pharmazie. 346(2). 127–133. 10 indexed citations
20.
Wu, Shanguang, Jianhua Sun, Zhangfa Tong, et al.. (2012). Rapid and simple colorimetric assay for screening angiotensin I-converting enzyme inhibitors. Pharmaceutical Biology. 50(10). 1303–1309. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026